I
Ilyang Pharmaceutical Co Ltd
KRX:007570
Ilyang Pharmaceutical Co Ltd
KRX:007570
Price:
13 050
KRW
Market Closed
Market Cap:
₩254.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
I
|
Ilyang Pharmaceutical Co Ltd
KRX:007570
|
KR |
|
P
|
Para Light Electronics Co Ltd
TWSE:6226
|
TW |
Multiples-Based Value
The Multiples-Based Value of one Ilyang Pharmaceutical Co Ltd stock under the Base Case scenario is 14 538.91 KRW. Compared to the current market price of 13 050 KRW, Ilyang Pharmaceutical Co Ltd is Undervalued by 10%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Multiples-Based Value
Base Case
14 538.91
KRW
Undervaluation 10%
I
Multiples Across Competitors
Competitors Multiples
Ilyang Pharmaceutical Co Ltd Competitors
Ilyang Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
I
|
Ilyang Pharmaceutical Co Ltd
KRX:007570
|
233.9B KRW | 0.9 | 34.8 | 24.7 | 66.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
875.9B USD | 13.4 | 42.4 | 28.6 | 30.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
580.2B USD | 6.2 | 21.6 | 15 | 18.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP | 5.2 | 30.2 | 16.7 | 23.5 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.7 | 11.6 | 13.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD | 4.6 | 16.4 | 10.2 | 12.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF | 5.2 | 20.8 | 12.9 | 16.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.2 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
158.2B USD | 2.5 | 20.4 | 7.8 | 10.4 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.4B USD | 2.5 | 16.9 | 7.1 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
